Thy-1 (CD90) promotes bone formation and protects against obesity
Standard
Thy-1 (CD90) promotes bone formation and protects against obesity. / Picke, Ann-Kristin; Campbell, Graeme M; Blüher, Matthias; Krügel, Ute; Schmidt, Felix N; Tsourdi, Elena; Winzer, Maria; Rauner, Martina; Vukicevic, Vladimir; Busse, Björn; Salbach-Hirsch, Juliane; Tuckermann, Jan P; Simon, Jan C; Anderegg, Ulf; Hofbauer, Lorenz C; Saalbach, Anja.
In: SCI TRANSL MED, Vol. 10, No. 453, 08.08.2018, p. eaao6806 .Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Thy-1 (CD90) promotes bone formation and protects against obesity
AU - Picke, Ann-Kristin
AU - Campbell, Graeme M
AU - Blüher, Matthias
AU - Krügel, Ute
AU - Schmidt, Felix N
AU - Tsourdi, Elena
AU - Winzer, Maria
AU - Rauner, Martina
AU - Vukicevic, Vladimir
AU - Busse, Björn
AU - Salbach-Hirsch, Juliane
AU - Tuckermann, Jan P
AU - Simon, Jan C
AU - Anderegg, Ulf
AU - Hofbauer, Lorenz C
AU - Saalbach, Anja
N1 - Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
PY - 2018/8/8
Y1 - 2018/8/8
N2 - Osteoporosis and obesity result from disturbed osteogenic and adipogenic differentiation and present emerging challenges for our aging society. Because of the regulatory role of Thy-1 in mesenchyme-derived fibroblasts, we investigated the impact of Thy-1 expression on mesenchymal stem cell (MSC) fate between osteogenic and adipogenic differentiation and consequences for bone formation and adipose tissue development in vivo. MSCs from Thy-1-deficient mice have decreased osteoblast differentiation and increased adipogenic differentiation compared to MSCs from wild-type mice. Consistently, Thy-1-deficient mice exhibited decreased bone volume and bone formation rate with elevated cortical porosity, resulting in lower bone strength. In parallel, body weight, subcutaneous/epigonadal fat mass, and bone fat volume were increased. Thy-1 deficiency was accompanied by reduced expression of specific Wnt ligands with simultaneous increase of the Wnt inhibitors sclerostin and dickkopf-1 and an altered responsiveness to Wnt. We demonstrated that disturbed bone remodeling in osteoporosis and dysregulated adipose tissue accumulation in patients with obesity were mirrored by reduced serum Thy-1 concentrations. Our findings provide new insights into the mutual regulation of bone formation and obesity and open new perspectives to monitor and to interfere with the dysregulated balance of adipogenesis and osteogenesis in obesity and osteoporosis.
AB - Osteoporosis and obesity result from disturbed osteogenic and adipogenic differentiation and present emerging challenges for our aging society. Because of the regulatory role of Thy-1 in mesenchyme-derived fibroblasts, we investigated the impact of Thy-1 expression on mesenchymal stem cell (MSC) fate between osteogenic and adipogenic differentiation and consequences for bone formation and adipose tissue development in vivo. MSCs from Thy-1-deficient mice have decreased osteoblast differentiation and increased adipogenic differentiation compared to MSCs from wild-type mice. Consistently, Thy-1-deficient mice exhibited decreased bone volume and bone formation rate with elevated cortical porosity, resulting in lower bone strength. In parallel, body weight, subcutaneous/epigonadal fat mass, and bone fat volume were increased. Thy-1 deficiency was accompanied by reduced expression of specific Wnt ligands with simultaneous increase of the Wnt inhibitors sclerostin and dickkopf-1 and an altered responsiveness to Wnt. We demonstrated that disturbed bone remodeling in osteoporosis and dysregulated adipose tissue accumulation in patients with obesity were mirrored by reduced serum Thy-1 concentrations. Our findings provide new insights into the mutual regulation of bone formation and obesity and open new perspectives to monitor and to interfere with the dysregulated balance of adipogenesis and osteogenesis in obesity and osteoporosis.
KW - Journal Article
U2 - 10.1126/scitranslmed.aao6806
DO - 10.1126/scitranslmed.aao6806
M3 - SCORING: Journal article
C2 - 30089635
VL - 10
SP - eaao6806
JO - SCI TRANSL MED
JF - SCI TRANSL MED
SN - 1946-6234
IS - 453
ER -